Shanghai Maiwei is good at biology. According to the search information of relevant websites, Maiwei (Shanghai) Biotechnology Co., Ltd. is committed to the research and development and manufacture of macromolecular innovative drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins, covering tumor, autoimmune, anti-infection, ophthalmology and other fields. , and was successfully listed on June 8, 2022.